Brendel, C., Hänseler, W., Wohlgensinger, V., Bianchi, M., Tokmak, S., Chen-Wichmann, L., . . . Siler, U. (2013). Human miR223 Promoter as a Novel Myelo-Specific Promoter for Chronic Granulomatous Disease Gene Therapy. Mary Ann Liebert, Inc.
استشهاد بنمط شيكاغوBrendel, Christian, et al. Human MiR223 Promoter As a Novel Myelo-Specific Promoter for Chronic Granulomatous Disease Gene Therapy. Mary Ann Liebert, Inc, 2013.
MLA استشهادBrendel, Christian, et al. Human MiR223 Promoter As a Novel Myelo-Specific Promoter for Chronic Granulomatous Disease Gene Therapy. Mary Ann Liebert, Inc, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.